WIPO Conference Tackles IP-Health Dynamic 21/09/2007 by Paul Garwood for Intellectual Property Watch Leave a Comment By Paul Garwood Intellectual property can help improve public health, but drug research costs must be controlled so patients in poor countries can afford urgently needed medicines, a World Intellectual Property Organization symposium heard Wednesday. The Geneva-staged event, at which representatives of United Nations bodies, foreign missions, non-governmental bodies and industry spoke, was held in […]
Concern Rises Over EU Bilaterals With Developing Countries 20/09/2007 by David Cronin for Intellectual Property Watch Leave a Comment By David Cronin for Intellectual Property Watch BRUSSELS – Concern is growing in both Europe and developing countries about whether a series of free trade agreements slated for signature later this year will contain overly stringent rules on intellectual property. The European Union’s executive, the European Commission, has proposed that the Economic Partnership Agreements it […]
Development Agenda Implementation Discussed Before WIPO Assemblies 18/09/2007 by Paul Garwood for Intellectual Property Watch Leave a Comment By Paul Garwood More technical assistance to developing countries, closer collaboration between UN agencies and overhauling the World Intellectual Property Organization were among calls made during a conference of leading players in the intellectual property community held Monday. The conference, entitled “The Reform of WIPO: Implementing the Development Agenda,” was the second such event. The […]
IP And Bioethics: International Community Seeking Answers 18/09/2007 by Catherine Saez, Intellectual Property Watch 1 Comment By Catherine Saez In order to explore the relationship between intellectual property rights and life science innovations, the World Intellectual Property Organization (WIPO) is organising policy symposia to identify and clarify the intellectual property dimension in the life sciences. In a world where biotechnology is booming and new technological frontiers are being crossed, new challenges arise such as ethical questions relating to the implication and applications of biological research. Patent agencies, industry and civil society were invited on 4 September to share their thoughts and experience on the use of the intellectual property system in bioethics. As Antony Taubman, acting director of the WIPO Global IP Issues Division described it, biotechnology is based on living organisms which raises distinct ethical questions.
Kenya Rejects Bid To Remove Government’s Compulsory Licensing Flexibilities 14/09/2007 by Paul Garwood for Intellectual Property Watch 1 Comment By Paul Garwood Kenya’s Parliament has rejected a proposal to revoke the government’s powers to issue compulsory licenses to manufacture products such as generic medicines without patent holder approval, a move welcomed Friday by supporters of universal access to pharmaceuticals. The decision, made late Wednesday, protects Kenya’s ability to acquire affordable generic medicines, such as […]
Kenyan Parliament To Debate Scrapping Compulsory Licensing Powers 12/09/2007 by Paul Garwood for Intellectual Property Watch Leave a Comment By Paul Garwood Kenyan lawmakers are set to debate proposed amendments to a bill that, if passed, would prevent the government from issuing compulsory licenses to produce urgently needed medicines without seeking approval from the patent holder. The amendments, which involve deleting parts of Kenya’s Industrial Property Act of 2001, were first expected to be […]
Data Mining: Consumers’ Convenience, Privacy’s End 12/09/2007 by Monika Ermert for Intellectual Property Watch Leave a Comment By Monika Ermert for Intellectual Property Watch LINZ, AUSTRIA – How distant is the realisation of a “prevision” and prevention culture as portrayed in the Steven Spielberg movie Minority Report? Telling the future is not as far off as critical minds might hope for, US author and activist Brian Holmes warned at the Ars Electronica, […]
EU Split Arises Over Thai Effort To Obtain Cheaper Patented Drugs 05/09/2007 by David Cronin for Intellectual Property Watch 1 Comment By David Cronin for Intellectual Property Watch A dispute has erupted between two of the European Union’s most powerful institutions over Thailand’s decision to circumvent pharmaceutical patents in order to boost its supply of cheap medicines. Peter Mandelson, who holds the trade portfolio in the EU’s executive arm, the European Commission, recently wrote to several […]
Rejected Novartis Cases Leave India’s TRIPS Compliance Unchallenged 07/08/2007 by Tatum Anderson for Intellectual Property Watch 1 Comment By Tatum Anderson for Intellectual Property Watch As Indian lawyers for Swiss pharmaceutical firm Novartis comb through a High Court judgment published today, the question of whether the Indian patent law is compliant with a World Trade Organization treaty remains unanswered. The judgment, from the Indian High Court in Chennai, threw out two highly contentious […]
UN Body Offers Guidance To Governments On Boosting IP Systems 30/07/2007 by William New, Intellectual Property Watch Leave a Comment By William New The World Intellectual Property Organization may be the biggest United Nations agency in Geneva working on IP issues, but another body also has taken up the effort. And in a recent conference held by the UN Economic Commission for Europe (UNECE), panels of experts informed officials from economies in transition about technology […]